The Latest Breaking News from FDA

The health of older women is a largely neglected group in medical research.

Government officials say Dollar Tree stores failed to effectively recall lead-tainted applesauce pouches linked to illness in more than 500 U.S. children

An early article from what will eventually be several on Information as Medicine.

Democratic and leftist groups prepare for potential challenges to abortion access under a Trump administration, with blue state governors stockpiling Mifep...

Are the risks and costs worth it to keep crow's feet at bay? Experts weigh in.

Erin Fox has tracked drug shortages for more than 20 years, and she sees no easy solutions for what has become a record run

Exclusive: Rishi Sunak’s team helped fast-track deal with firm founded by Charles Huang, who says contracts generated $2bn profit

FDA warns against Diamond Shruumz microdosing chocolate bars causing hospitalizations. Investigation ongoing.

Ongoing legal battle over mifepristone access and reproductive rights following Supreme Court ruling.

Attorneys general across the U.S. have a new fight on their hands: protecting Americans from unproven and expensive stem cell treatments that salespeople claim can cure almost anything

The recent Supreme Court ruling on technical grounds has upheld the availability of the abortion pill mifepristone in the United States. While this decision is a temporary win for abortion rights advocates, it is not the final word on the issue, and there are indications that opponents of abortion will…